This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties [1] [2] , and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis [3] [4]
NICE recommends these early in treatment for many people with established cardiovascular disease or chronic kidney disease [3] Pioglitazone : An insulin sensitiser, though less commonly used due to side effects including weight gain and fluid retention DPP-4 inhibitors : These enhance incretin activity with a lower side effect burden than GLP-1 agonists but less weight loss benefit Tirzepatide : A newer dual GIP/GLP-1 receptor agonist available for type 2 diabetes (subject to local formulary approval) [3] For patients who cannot tolerate or do not respond adequately to Ozempic, other GLP-1 receptor agonists such as dulaglutide (Trulicity) or liraglutide (Victoza) may be considered
Clinical Recommendation for Use Apply topically as directed by your skincare professional
As per April data, Torrent posted about Rs 17 crore in sales, far exceeding rivals such as Zydus Lifesciences, Dr Reddys Laboratories and Lupin (about Rs 4 crore each), Alkem and Eris (about Rs 3.4 crore each) and Sun Pharma and USV (about Rs 2.3 crore each)
